News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
707,158 Results
Type
Article (45485)
Company Profile (371)
Press Release (661302)
Section
Business (207895)
Career Advice (2022)
Deals (35834)
Drug Delivery (101)
Drug Development (82610)
Employer Resources (171)
FDA (16454)
Job Trends (15227)
News (351664)
Policy (33534)
Tag
Academia (2713)
Alliances (50451)
Alzheimer's disease (1282)
Approvals (16397)
Artificial intelligence (154)
Bankruptcy (353)
Best Places to Work (11953)
Biotechnology (265)
Breast cancer (194)
Cancer (1401)
Cardiovascular disease (113)
Career advice (1686)
Cell therapy (291)
Clinical research (65946)
Collaboration (500)
Compensation (267)
COVID-19 (2622)
C-suite (115)
Data (1407)
Diabetes (184)
Diagnostics (6304)
Earnings (85753)
Employer resources (149)
Events (112821)
Executive appointments (401)
FDA (17137)
Funding (440)
Gene therapy (211)
GLP-1 (641)
Government (4478)
Healthcare (19361)
Infectious disease (2716)
Inflammatory bowel disease (117)
Interviews (311)
IPO (16499)
Job creations (3713)
Job search strategy (1439)
Layoffs (433)
Legal (8113)
Lung cancer (201)
Lymphoma (100)
Manufacturing (216)
Medical device (13360)
Medtech (13365)
Mergers & acquisitions (19495)
Metabolic disorders (482)
Neuroscience (1611)
NextGen Class of 2024 (6721)
Non-profit (4625)
Northern California (1710)
Obesity (279)
Opinion (195)
Patents (118)
People (57886)
Phase I (20504)
Phase II (28927)
Phase III (21683)
Pipeline (520)
Postmarket research (2733)
Preclinical (8803)
Radiopharmaceuticals (245)
Rare diseases (273)
Real estate (6048)
Regulatory (22405)
Research institute (2443)
Resumes & cover letters (352)
Southern California (1474)
Startups (3693)
United States (15492)
Vaccines (584)
Weight loss (201)
Date
Last 7 days (598)
Last 30 days (2382)
Last 365 days (35995)
2024 (35831)
2023 (40879)
2022 (52078)
2021 (56664)
2020 (55095)
2019 (47738)
2018 (36024)
2017 (32932)
2016 (32515)
2015 (38561)
2014 (32248)
2013 (27564)
2012 (29709)
2011 (30270)
2010 (28295)
Location
Africa (763)
Arizona (200)
Asia (38791)
Australia (6384)
California (3878)
Canada (1457)
China (310)
Colorado (178)
Connecticut (186)
Europe (84239)
Florida (541)
Georgia (142)
Illinois (401)
Indiana (229)
Maryland (640)
Massachusetts (3053)
Michigan (174)
Minnesota (295)
New Jersey (1127)
New York (1099)
North Carolina (786)
Northern California (1710)
Ohio (146)
Pennsylvania (931)
South America (1121)
Southern California (1474)
Texas (555)
Utah (109)
Washington State (411)
707,158 Results for "rheos medicines inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Genomadix Inc. Enters into Collaboration with Mayo Clinic on Precision Medicine for Telestroke
November 15, 2024
·
2 min read
Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
Oragenics, Inc. today announced that the company will host a webinar panel on Neurotrauma Medicine Monday, May 20, 2024, at 12:00 PM ET.
May 17, 2024
·
3 min read
Press Releases
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best- and First-in-Class Ophthalmic Medicines
December 12, 2024
·
4 min read
Press Releases
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.
November 8, 2024
·
6 min read
Genetown
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024
Praxis Precision Medicines, Inc. announced that on June 3, 2024, the Compensation Committee of Praxis’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 300 shares of its common stock and restricted stock unit awards covering an aggregate of 225 shares of its common stock to one new non-executive employee under the Praxis Precision Medicines, Inc. 2024 Inducement Plan.
June 4, 2024
·
2 min read
BioMidwest
Waters Advances Battery Electrode Design and Performance Analysis with New Rheo-IS Accessory
Waters Corporation announced a new accessory for its TA Instruments Discovery Hybrid Rheometers designed to enable simultaneous electrical impedance and rheological measurements, a critical capability for scientists working on new battery formulations.
March 13, 2024
·
4 min read
Genetown
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2024
Praxis Precision Medicines, Inc. announced that on May 1, 2024, the Compensation Committee of Praxis’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 7,800 shares of its common stock and restricted stock unit awards covering an aggregate of 5,851 shares of its common stock to six new non-executive employees under the Praxis Precision Medicines, Inc.
May 3, 2024
·
2 min read
Business
Rheos Medicines Announces New Scientific Advisory Board Members
Rheos Medicines today announced that it has appointed Soumya Raychaudhuri, M.D., Ph.D., and Cornelia Weyand, M.D., to its Scientific Advisory Board (SAB).
April 14, 2022
·
5 min read
Press Releases
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease
November 20, 2024
·
5 min read
1 of 70,716
Next
